Ginkgo Bioworks (NYSE: DNA) revenue
Ginkgo Bioworks reported revenue of $170.2m for fiscal 2025, 25.1% less than in fiscal 2024 ($227.0m). Since fiscal 2020 its revenue has grown by 122.0%, an average growth of 17.3% a year.
Ginkgo Bioworks's revenue has fallen for 3 years in a row, and its best year of the last 6 was fiscal 2022. The biggest drop was in fiscal 2023, −47.4%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $170.2m | −25.1% | −$315.3m | −185.3% |
| 2024 | $227.0m | −9.7% | −$559.8m | −246.5% |
| 2023 | $251.5m | −47.4% | −$864.4m | −343.8% |
| 2022 | $477.7m | +52.2% | −$2,209m | −462.4% |
| 2021 | $313.8m | +309.4% | −$1,828m | −582.6% |
| 2020 | $76.7m | — | −$137.0m | −178.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ginkgo Bioworks revenue compared with its sector
By revenue for its latest fiscal year, Ginkgo Bioworks ranks 258th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ginkgo Bioworks, −25.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 256th | Syndax Pharmaceuticals | $172.4m | 627.8% |
| 257th | Regenxbio | $170.4m | 104.5% |
| 258th | Ginkgo Bioworks | $170.2m | −25.1% |
| 259th | Pacific Biosciences of California | $160.0m | 3.9% |
| 260th | Liquidia | $158.3m | 1,031.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Ginkgo Bioworks
- How much revenue did Ginkgo Bioworks make in fiscal 2025?
- Ginkgo Bioworks reported revenue of $170.2m for fiscal 2025, compared with $227.0m in fiscal 2024.
- How much has the revenue of Ginkgo Bioworks grown?
- Between fiscal 2020 and fiscal 2025 it went from $76.7m to $170.2m: 122.0% more, an average growth of 17.3% a year.
- What was the best year for revenue at Ginkgo Bioworks?
- Of its last 6 fiscal years, fiscal 2022, with $477.7m.
- Where does Ginkgo Bioworks rank in its sector by revenue?
- It ranks 258th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Ginkgo Bioworks come from?
- From the annual report (Form 10-K) that Ginkgo Bioworks files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ginkgo Bioworks files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Ginkgo Bioworks: the Ginkgo Bioworks page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.